modelQuinidine

Diagram of Quinidine

Extends from Pharmacolibrary.Drugs.ATC.C.C01BA01.

Information

name:Quinidine
ATC code:C01BA01
route:oral
compartments:2
dosage:600mg
volume of distribution:2.5L
clearance:7.1mL/min/kg
other parameters in model implementation

Quinidine is a class Ia antiarrhythmic agent historically used to treat certain types of cardiac arrhythmias, such as atrial fibrillation and ventricular arrhythmias. It acts by blocking sodium channels and increasing the action potential duration. While quinidine is less commonly used today due to side effects and the availability of safer agents, it remains approved in some regions for specific arrhythmic indications.

Pharmacokinetics

Pharmacokinetics in healthy adult subjects following oral administration.

References

  1. Fattinger, K, et al., & Follath, F (1991). Population pharmacokinetics of quinidine. British journal of clinical pharmacology 31(3) 279–286. DOI:10.1111/j.1365-2125.1991.tb05531.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/2054269

  2. Verme, CN, et al., & Harris, SC (1992). Pharmacokinetics of quinidine in male patients. A population analysis. Clinical pharmacokinetics 22(6) 468–480. DOI:10.2165/00003088-199222060-00005 PUBMED:https://pubmed.ncbi.nlm.nih.gov/1587058

  3. Yin, OQ, et al., & Miller, R (2014). Edoxaban population pharmacokinetics and exposure-response analysis in patients with non-valvular atrial fibrillation. European journal of clinical pharmacology 70(11) 1339–1351. DOI:10.1007/s00228-014-1736-4 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25168620

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)